Drug profile · INN
deferoxamine mesylate
DEFEROXAMINE MESYLATE
deferoxamine mesylate (DEFEROXAMINE MESYLATE) is a iron chelating agent. Route of administration: injection. Current US regulatory status: approved.
Drug details — deferoxamine mesylate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 5
- Programs
- 2
- Data quality
- 0.84
Quick answer
deferoxamine mesylate (DEFEROXAMINE MESYLATE) is a iron chelating agent. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Iron chelating agent
Primary target: Iron
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is deferoxamine mesylate?
deferoxamine mesylate (DEFEROXAMINE MESYLATE) is a iron chelating agent. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for deferoxamine mesylate?
DEFEROXAMINE MESYLATE is a marketed brand name for deferoxamine mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of deferoxamine mesylate?
deferoxamine mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.